Enerpac Tool Group Corp Reports Q1 Sales Decline
Enerpac Tool Group Corp's stock fell by 8.41% as it crossed below the 5-day SMA, reflecting a challenging quarter for the company.
The decline in stock price is attributed to a reported decrease in Q1 net sales to $144 million, a 1% year-over-year decline, primarily driven by a 3% organic sales decline in the IT&S segment. Despite Cortland Biomedical's impressive 27% growth, the overall performance indicates market demand variability. Additionally, the company's earnings of $19.1 million and diluted EPS of $0.36 fell short of last year's figures, reflecting profitability fluctuations amid broader market strength.
This performance highlights the challenges Enerpac faces in a competitive environment, despite maintaining a stable outlook for fiscal 2026 with projected sales between $635 million and $655 million.
Trade with 70% Backtested Accuracy
Analyst Views on EPAC
About EPAC
About the author
Enerpac Tool Group to Release Q2 Fiscal 2026 Earnings on March 25
- Earnings Release Schedule: Enerpac Tool Group announced it will release its Q2 fiscal 2026 earnings after market close on March 25, 2026, with management emphasizing transparency and investor communication through a follow-up conference call on March 26.
- Conference Call Details: The call is scheduled for 8:30 a.m. ET on March 26, providing a real-time webcast for investors, while a replay will be available for 90 days, ensuring all stakeholders can access critical information regardless of their availability.
- Company Background: Founded in 1910 and headquartered in Milwaukee, Wisconsin, Enerpac Tool Group is a leading provider of industrial tools and solutions, serving customers in over 100 countries, highlighting its leadership in high-pressure hydraulic tools and precise load positioning solutions.
- Market Positioning and Impact: The company focuses on delivering safe and efficient solutions for complex and hazardous jobs, showcasing its significance in the global market and responsiveness to customer needs, thereby reinforcing its competitive edge in the industrial tools sector.
Transcript of Enerpac (EPAC) Q1 2026 Earnings Call
- Author's Perspective: The views and opinions presented are solely those of the author.
- No Official Endorsement: The content does not necessarily reflect the views of Nasdaq, Inc.
Enerpac Tool Group Corp. Sees Decline in Q1 Profit
Earnings Decline: Enerpac Tool Group Corp. reported a decrease in earnings for the first quarter, with net earnings of $19.13 million ($0.36 per share) compared to $21.72 million ($0.40 per share) in the same period last year.
Adjusted Earnings: Excluding certain items, the adjusted earnings for the quarter were $19.20 million, maintaining the same earnings per share of $0.36.
Revenue Decrease: The company's revenue fell by 0.7%, totaling $144.21 million, down from $145.20 million in the previous year.
Financial Summary: Key financial figures include earnings of $19.13 million, EPS of $0.36, and revenue of $144.21 million, all reflecting a decline compared to the previous year.
Enerpac Reports $144M in Q1 Sales, $15M Returned to Shareholders
- Sales Decline: Enerpac's Q1 net sales reached $144 million, a 1% decrease year-over-year, primarily driven by a 3% organic sales decline in the IT&S segment, although Cortland Biomedical achieved a notable 27% growth, indicating market demand variability.
- Profitability Fluctuations: The company reported net earnings of $19.1 million and diluted EPS of $0.36, down from $21.7 million and $0.40 in the prior year, reflecting a decrease in gross margin and slight operating expense deleveraging.
- Cash Flow Improvement: Operating cash flow increased to $16 million from $8.6 million in the previous year, demonstrating enhanced cash management and operational efficiency, which supports future investments and shareholder returns.
- Stable Outlook: Enerpac maintains its fiscal 2026 sales outlook, projecting net sales between $635 million and $655 million, reflecting the company's confidence in the market despite external economic uncertainties.
Enerpac Reports $144M in Q1 Sales, $15M Returned to Shareholders
- Sales Decline: Enerpac's Q1 net sales reached $144.2 million, a 1% decrease year-over-year, primarily driven by a 3% organic sales decline in the IT&S segment, although Cortland Biomedical saw a significant 27% growth, indicating market demand disparities.
- Profitability Decline: The company reported net earnings of $19.1 million and diluted EPS of $0.36, down from $21.7 million and $0.40 in the prior year, reflecting lower gross margins and slight increases in operating expenses.
- Cash Flow Improvement: Operating cash flow improved to $16 million from $8.6 million in the previous year, indicating better cash management that supports future investments and shareholder returns.
- Shareholder Return Program: In Q1, the company repurchased approximately 377,000 shares for about $14.9 million, demonstrating a commitment to shareholder value while laying the groundwork for future returns.
Enerpac (EPAC) Reports Q1 Earnings and Revenues Below Expectations
Earnings Performance: Enerpac (EPAC) reported quarterly earnings of $0.36 per share, missing the Zacks Consensus Estimate of $0.37, and showing a decline from $0.40 per share a year ago. The company has surpassed consensus EPS estimates only once in the last four quarters.
Revenue Results: The company posted revenues of $144.21 million for the quarter, falling short of the Zacks Consensus Estimate by 2.43% and down from $145.2 million year-over-year. Enerpac has exceeded revenue estimates twice in the past four quarters.
Stock Outlook: Enerpac shares have decreased by 4.1% since the start of the year, contrasting with the S&P 500's 15.6% gain. The stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Industry Context: The Manufacturing - Tools & Related Products industry ranks in the top 7% of Zacks industries, suggesting a favorable outlook. Investors are encouraged to monitor earnings estimate revisions, which can significantly influence stock performance.
Enerpac Tool Group to Release Q2 Fiscal 2026 Earnings on March 25
- Earnings Release Schedule: Enerpac Tool Group announced it will release its Q2 fiscal 2026 earnings after market close on March 25, 2026, with management emphasizing transparency and investor communication through a follow-up conference call on March 26.
- Conference Call Details: The call is scheduled for 8:30 a.m. ET on March 26, providing a real-time webcast for investors, while a replay will be available for 90 days, ensuring all stakeholders can access critical information regardless of their availability.
- Company Background: Founded in 1910 and headquartered in Milwaukee, Wisconsin, Enerpac Tool Group is a leading provider of industrial tools and solutions, serving customers in over 100 countries, highlighting its leadership in high-pressure hydraulic tools and precise load positioning solutions.
- Market Positioning and Impact: The company focuses on delivering safe and efficient solutions for complex and hazardous jobs, showcasing its significance in the global market and responsiveness to customer needs, thereby reinforcing its competitive edge in the industrial tools sector.
Transcript of Enerpac (EPAC) Q1 2026 Earnings Call
- Author's Perspective: The views and opinions presented are solely those of the author.
- No Official Endorsement: The content does not necessarily reflect the views of Nasdaq, Inc.
Enerpac Tool Group Corp. Sees Decline in Q1 Profit
Earnings Decline: Enerpac Tool Group Corp. reported a decrease in earnings for the first quarter, with net earnings of $19.13 million ($0.36 per share) compared to $21.72 million ($0.40 per share) in the same period last year.
Adjusted Earnings: Excluding certain items, the adjusted earnings for the quarter were $19.20 million, maintaining the same earnings per share of $0.36.
Revenue Decrease: The company's revenue fell by 0.7%, totaling $144.21 million, down from $145.20 million in the previous year.
Financial Summary: Key financial figures include earnings of $19.13 million, EPS of $0.36, and revenue of $144.21 million, all reflecting a decline compared to the previous year.
Enerpac Reports $144M in Q1 Sales, $15M Returned to Shareholders
- Sales Decline: Enerpac's Q1 net sales reached $144 million, a 1% decrease year-over-year, primarily driven by a 3% organic sales decline in the IT&S segment, although Cortland Biomedical achieved a notable 27% growth, indicating market demand variability.
- Profitability Fluctuations: The company reported net earnings of $19.1 million and diluted EPS of $0.36, down from $21.7 million and $0.40 in the prior year, reflecting a decrease in gross margin and slight operating expense deleveraging.
- Cash Flow Improvement: Operating cash flow increased to $16 million from $8.6 million in the previous year, demonstrating enhanced cash management and operational efficiency, which supports future investments and shareholder returns.
- Stable Outlook: Enerpac maintains its fiscal 2026 sales outlook, projecting net sales between $635 million and $655 million, reflecting the company's confidence in the market despite external economic uncertainties.
Enerpac Reports $144M in Q1 Sales, $15M Returned to Shareholders
- Sales Decline: Enerpac's Q1 net sales reached $144.2 million, a 1% decrease year-over-year, primarily driven by a 3% organic sales decline in the IT&S segment, although Cortland Biomedical saw a significant 27% growth, indicating market demand disparities.
- Profitability Decline: The company reported net earnings of $19.1 million and diluted EPS of $0.36, down from $21.7 million and $0.40 in the prior year, reflecting lower gross margins and slight increases in operating expenses.
- Cash Flow Improvement: Operating cash flow improved to $16 million from $8.6 million in the previous year, indicating better cash management that supports future investments and shareholder returns.
- Shareholder Return Program: In Q1, the company repurchased approximately 377,000 shares for about $14.9 million, demonstrating a commitment to shareholder value while laying the groundwork for future returns.
Enerpac (EPAC) Reports Q1 Earnings and Revenues Below Expectations
Earnings Performance: Enerpac (EPAC) reported quarterly earnings of $0.36 per share, missing the Zacks Consensus Estimate of $0.37, and showing a decline from $0.40 per share a year ago. The company has surpassed consensus EPS estimates only once in the last four quarters.
Revenue Results: The company posted revenues of $144.21 million for the quarter, falling short of the Zacks Consensus Estimate by 2.43% and down from $145.2 million year-over-year. Enerpac has exceeded revenue estimates twice in the past four quarters.
Stock Outlook: Enerpac shares have decreased by 4.1% since the start of the year, contrasting with the S&P 500's 15.6% gain. The stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Industry Context: The Manufacturing - Tools & Related Products industry ranks in the top 7% of Zacks industries, suggesting a favorable outlook. Investors are encouraged to monitor earnings estimate revisions, which can significantly influence stock performance.
